Furthermore, a 2024 study revealed that CD8+ T-cell–derived IFN-γ promotes AAA formation in mice, suggesting that regulation of this pathway could represent a novel therapeutic direction [153]. The gene discussed is IFNG; the disease is triple-A syndrome.